glp-1 conference Moving Beyond GLP-1: The Next Wave of Innovation in Obesity Treatment GLP-1-Based Therapeutics Summit | Conference

Metopimazine has never been evaluated for the treatment of gastroparesis

The role of glucose in cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: A systematic review of observational studies

Here's what it doesn't mean: those results came from the FDA-approved Wegovy formulation in a controlled trial setting, with a specific patient population, a specific dosing protocol, and lifestyle intervention built in

Upon waking, drink 500ml of room temperature water before doing anything else

Obesity itself is one of the most underrecognized causes of low milk supply, working through several mechanisms: excess fat tissue slows the hormonal shift that "turns on" full milk production after delivery, high leptin levels interfere with prolactin response, and insulin resistance (extremely common in obesity) disrupts the metabolic signaling your mammary gland needs to produce milk efficiently

The Nexplanon FAERS Report Summary at AskaPatient lists more than 5,000 device-related complication issues, including more than 2,000 reports of device dislocation (most reports submitted by Organon)